- Home
- FUL vs PTGX Comparison
FUL vs PTGX Comparison
Compare FUL & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUL
- PTGX
- Stock Information
- Founded
- FUL 1887
- PTGX 2006
- Country
- FUL United States
- PTGX United States
- Employees
- FUL N/A
- PTGX N/A
- Industry
- FUL Home Furnishings
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- FUL Industrials
- PTGX Health Care
- Exchange
- FUL Nasdaq
- PTGX Nasdaq
- Market Cap
- FUL 2.9B
- PTGX 2.8B
- IPO Year
- FUL N/A
- PTGX 2016
- Fundamental
- Price
- FUL $54.59
- PTGX $44.99
- Analyst Decision
- FUL Hold
- PTGX Strong Buy
- Analyst Count
- FUL 5
- PTGX 8
- Target Price
- FUL $62.50
- PTGX $66.50
- AVG Volume (30 Days)
- FUL 453.9K
- PTGX 1.1M
- Earning Date
- FUL 06-25-2025
- PTGX 05-06-2025
- Dividend Yield
- FUL 1.71%
- PTGX N/A
- EPS Growth
- FUL N/A
- PTGX N/A
- EPS
- FUL 1.99
- PTGX 0.86
- Revenue
- FUL $3,546,980,000.00
- PTGX $207,801,000.00
- Revenue This Year
- FUL N/A
- PTGX N/A
- Revenue Next Year
- FUL $3.50
- PTGX $7.13
- P/E Ratio
- FUL $27.52
- PTGX $50.92
- Revenue Growth
- FUL 0.99
- PTGX N/A
- 52 Week Low
- FUL $47.56
- PTGX $24.22
- 52 Week High
- FUL $87.67
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- FUL 51.90
- PTGX 49.93
- Support Level
- FUL $52.37
- PTGX $41.29
- Resistance Level
- FUL $54.90
- PTGX $46.12
- Average True Range (ATR)
- FUL 1.28
- PTGX 1.74
- MACD
- FUL 0.13
- PTGX -0.06
- Stochastic Oscillator
- FUL 50.57
- PTGX 61.14
About FUL H. B. Fuller Company
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.